Hagop Kantarjian Selected Research

Hagop Kantarjian Research Topics

Disease

223	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2024 - 01/2000
205	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 01/2002
128	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2024 - 03/2002
123	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2024 - 01/2002
123	Neoplasms (Cancer) 02/2024 - 01/2002
123	Leukemia 12/2023 - 03/2002
85	Philadelphia Chromosome 04/2024 - 02/2002
40	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 03/2002
39	Primary Myelofibrosis (Myelosclerosis) 04/2024 - 09/2002
34	Hematologic Neoplasms (Hematological Malignancy) 05/2023 - 01/2002
28	Acute Promyelocytic Leukemia 02/2024 - 05/2003
25	Thrombocytopenia (Thrombopenia) 04/2023 - 04/2004
25	Blast Crisis (Blast Phase) 01/2023 - 10/2002
24	Residual Neoplasm 12/2022 - 11/2006
22	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 04/2023 - 06/2002
18	Infections 11/2023 - 03/2003
18	Disease Progression 04/2023 - 05/2002
18	Anemia 01/2023 - 03/2002
18	Myeloid Leukemia (Leukemia, Myelocytic) 01/2021 - 04/2006
16	Chromosome Aberrations (Chromosome Abnormalities) 01/2023 - 05/2002
15	Lymphoma (Lymphomas) 01/2022 - 06/2005
12	Neutropenia 04/2024 - 09/2003
12	Splenomegaly 04/2024 - 03/2002
12	Pneumonia (Pneumonitis) 01/2024 - 01/2003
11	Exanthema (Rash) 11/2023 - 06/2009
11	Myeloproliferative Disorders (Myeloproliferative Disorder) 06/2008 - 09/2002
10	Multiple Myeloma 10/2017 - 03/2003
10	Polycythemia Vera 04/2017 - 06/2003
9	Nausea 11/2023 - 10/2002
9	Hemorrhage 01/2023 - 06/2009
9	Pathologic Complete Response 07/2020 - 01/2003
9	Hypereosinophilic Syndrome (Loeffler Endocarditis) 06/2013 - 09/2002
8	Fever (Fevers) 11/2023 - 01/2003
8	Hypertension (High Blood Pressure) 01/2023 - 01/2011
7	Sepsis (Septicemia) 01/2024 - 08/2004
7	Cytopenia 11/2022 - 06/2007
7	Diarrhea 01/2017 - 12/2003
7	Systemic Mastocytosis 09/2013 - 05/2004
7	Essential Thrombocythemia 08/2013 - 01/2003
6	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2024 - 03/2003

Drug/Important Bio-Agent (IBA)

149	Imatinib Mesylate (Gleevec)FDA Link 12/2023 - 01/2000
96	Tyrosine Kinase InhibitorsIBA 03/2024 - 11/2006
62	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2024 - 03/2002
41	Dasatinib (BMS 354825)FDA Link 04/2024 - 06/2006
41	Decitabine FDA Link 02/2024 - 03/2003
32	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2002
30	Phosphotransferases (Kinase)IBA 01/2023 - 12/2003
28	Azacitidine (5 Azacytidine)FDA Link 01/2024 - 01/2005
25	fludarabineIBA 01/2023 - 03/2003
24	venetoclaxIBA 04/2024 - 03/2014
23	Inotuzumab OzogamicinIBA 05/2024 - 06/2013
23	ponatinibIBA 04/2024 - 11/2012
23	Rituximab (Mabthera)FDA Link 12/2021 - 11/2003
23	nilotinib FDA Link 03/2016 - 07/2005
22	bcr-abl Fusion ProteinsIBA 01/2022 - 01/2000
21	blinatumomabIBA 02/2024 - 01/2017
21	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 03/2002
21	Monoclonal AntibodiesIBA 01/2021 - 09/2004
20	Arsenic Trioxide (Trisenox)FDA Link 02/2024 - 05/2003
19	Clofarabine (Clolar)FDA Link 01/2021 - 10/2003
18	Vincristine (Oncovin)FDA LinkGeneric 10/2021 - 03/2002
17	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2024 - 05/2003
17	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 11/2023 - 01/2003
15	Gemtuzumab (Mylotarg)FDA Link 11/2022 - 01/2002
15	InterferonsIBA 01/2021 - 03/2003
14	ruxolitinibIBA 01/2023 - 04/2010
13	Biomarkers (Surrogate Marker)IBA 04/2024 - 06/2002
13	ibrutinibIBA 01/2023 - 06/2014
13	Core Binding Factors (Core-Binding Factor)IBA 01/2023 - 12/2008
13	Interferon-alpha (Interferon Alfa)IBA 06/2012 - 01/2000
12	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2024 - 03/2003
12	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 12/2003
12	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021 - 03/2002
12	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 03/2002
10	Sorafenib (BAY 43-9006)FDA Link 11/2023 - 12/2008
10	Lenalidomide (CC 5013)FDA Link 10/2022 - 05/2007
10	Hemoglobins (Hemoglobin)IBA 07/2018 - 06/2004
9	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2023 - 03/2002
9	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 06/2014
9	CytokinesIBA 12/2021 - 09/2002
9	fms-Like Tyrosine Kinase 3IBA 01/2020 - 05/2004
8	Alkylating AgentsIBA 02/2024 - 05/2004
8	BilirubinIBA 12/2023 - 04/2012
8	Indicators and Reagents (Reagents)IBA 12/2023 - 05/2006
8	Alemtuzumab (Campath)FDA Link 06/2013 - 11/2005
7	CreatinineIBA 12/2023 - 10/2008
7	HomoharringtonineIBA 01/2019 - 01/2007
7	Prednisone (Sone)FDA LinkGeneric 12/2018 - 09/2010
7	Methotrexate (Mexate)FDA LinkGeneric 01/2016 - 03/2002
7	tipifarnib (R115777)IBA 03/2011 - 10/2002

Therapy/Procedure

315	Therapeutics 04/2024 - 03/2002
113	Drug Therapy (Chemotherapy) 04/2024 - 03/2002
26	Stem Cell Transplantation 01/2024 - 07/2003
21	Salvage Therapy 01/2023 - 04/2003
15	Hematopoietic Stem Cell Transplantation 02/2024 - 02/2007
15	Induction Chemotherapy 12/2023 - 01/2003
8	Transplantation 01/2022 - 09/2003
7	Cell Transplantation 11/2022 - 01/2007
7	Drug Tapering 11/2020 - 12/2003
6	Immunotherapy 10/2023 - 12/2016